Regulus Therapeutics Inc
RGLS
|
|
| |
|
| Trading Volume | 2,731 |
|
|
2.89 - 1.13 |
| Market Cap Full | $ 33.2M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 1.3% | 125.8% | -38.1% | -6.8% |
| Q2 | - | -27.9% | 73.4% | 590% |
| Q3 | - | -9.9% | -6.1% | -17.9% |
| Q4 | - | 8.9% | -7.3% | -19.4% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.3 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -0.8 | 15.8 | 96.6 | -23.7 | 3 | -10.8 | -10.1 | -9.9 | - | - | - | -0.6 |
| 2023 | |||||||||||
| 5.1 | -6.9 | -36.7 | 56.8 | -2.3 | 13.1 | -4.8 | 11.4 | -11.5 | -11.6 | 8.2 | -3 |
| 2022 | |||||||||||
| -23.3 | -8.1 | 32.2 | -31.3 | 42.2 | 606.5 | -22.2 | -11.8 | 19.7 | -8.8 | 10.3 | -19.9 |
| 2021 | |||||||||||
| 3 | -8.6 | 22.8 | -10.9 | -28.8 | -18.2 | -13.1 | 10.8 | -11.4 | -33.3 | -16.1 | -16.8 |
| 2020 | |||||||||||
| 31.8 | -36.9 | -31.7 | 10.6 | 47.1 | -9.1 | 2.7 | -24.3 | -3.8 | -7.7 | 31.2 | 118.5 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.4 | -0.5 | -0.1 | -0.3 |
| Q2 | -0.4 | -0.5 | -0.1 | -0.2 |
| Q3 | -0.4 | -0.5 | -0.1 | -0 |
| Q4 | 0 | -0.4 | -0.7 | 0.1 |
| A | -1.19 | 1.9 | 3.2 | -0.5 |